FCF Research Grants

The Fanconi Cancer Foundation (FCF) seeks to fund interdisciplinary and translational research efforts that will lead to rapid discovery and development of therapies or strategies that treat, control, or cure Fanconi anemia (FA). Research proposals must address one or more of our research priorities:

Top Priority: To define the pathogenesis of Fanconi associated cancers, and to develop strategies for prevention, early detection, treatment, and cure.

Other Priorities:

• Novel Therapies: To develop ex vivo and in vivo gene therapy and gene editing technologies for FA.
• Bone Marrow Failure: To identify factors predictive of bone marrow failure, myelodysplastic syndrome, and leukemia, and associated treatment for high-risk populations.
• Manifestations of FA: To understand, prevent, and treat systemic, inflammatory, and aging manifestations of FA, including but not limited to: Fanconi Anemia Neurological Syndrome (FANS), endocrine and fertility issues.
• Quality of Life: To identify practical and proactive management strategies that families and persons with FA can use to develop and maintain a high quality of life.
• Data Analytics: To use data analytics to identify biomarkers, hypotheses, risk predictions, and treatment for FA.
• Resource Sharing: To develop shared research resources and systems for allocation (i.e., tissue samples, cell lines, model systems, and data).

Research Authority due date: 26.2.26

Pre proposal (required) due date: 6.3.26

Full proposal due date: 5.6.26